Trade Summary

4 days ago, Heier Jeffrey S., serving as Chief Scientific Officer at Ocular Therapeutix, Inc (OCUL), sold 3,057 shares at $8.28 per share, for a total transaction value of $25,312.00. Following this transaction, Heier Jeffrey S. now holds 323,368 shares of OCUL.

This sale represents a 1.00% decrease in Heier Jeffrey S.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, February 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 25, 2026, 2 days after the trade was made.

Ocular Therapeutix, Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.